
AXGN vs EYES
$AXGN vs $EYES head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
AXGN vs EYES: the quick read
- ·EYES is the larger company by market cap ($2.56B vs $2.38B).
- ·AXGN has been more active on our scanner (76 vs 0 alerts in 30 days).
- ·These sit in different industries (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS vs Electromedical & Electrotherapeutic Apparatus), so they answer to different catalysts and a move in one says little about the other.
- ·Only one of them shows up on our scanner: AXGN triggered 76 unusual-volume alerts in the last 30 days and the other triggered none.
- ·They are closely matched in size, within 8% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing AXGN and EYES on TheDesperateTrader.
- Is AXGN or EYES the better stock?
- "Better" depends on your goal, and these two are not alike. EYES is the larger company by market cap ($2.56B vs $2.38B). AXGN has been more active on our scanner (76 vs 0 alerts in 30 days). These sit in different industries (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS vs Electromedical & Electrotherapeutic Apparatus), so they answer to different catalysts and a move in one says little about the other. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between AXGN and EYES?
- The differences that matter: they are not in the same business - AXGN is electromedical & electrotherapeutic apparatus and EYES is electromedical & electrotherapeutic apparatus; they are similar in size ($2.38B vs $2.56B); they trade at very different share prices ($44.23 vs $28.47); AXGN sits at 77% of its 52-week range against 70% for EYES; our scanner flagged AXGN 76 times in the last 30 days against 0 for EYES. Everything above is measured from the latest completed session and SEC filings.
- Which of AXGN and EYES is more active right now?
- Right now AXGN is at about 1.0x its normal volume and EYES is at about 0.4x, so AXGN is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading AXGN or EYES? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore AXGN and EYES comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.